Topical roflumilast for the treatment of psoriasis.
Sign Up to like & getrecommendations! Published in 2023 at "Expert review of clinical immunology"
DOI: 10.1080/1744666x.2023.2219897
Abstract: INTRODUCTION New non-steroidal topical agents are needed for the treatment of psoriasis. Roflumilast cream 0.3% is a once daily phosphodiesterase-4 inhibitor that was recently approved by the FDA for the treatment of plaque psoriasis in… read more here.
Keywords: roflumilast treatment; treatment psoriasis; topical roflumilast; treatment ... See more keywords